Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
Single allele			not provided	Uncertain significance(Last reviewed: Apr 3, 2018)	criteria provided, single submitter	VCV000559471					559471	550195		
NM_020919.4(ALS2):c.2979+8del	ALS2		Infantile-onset ascending hereditary spastic paralysis	Likely benign(Last reviewed: Jan 20, 2020)	criteria provided, single submitter	VCV001078244	2	202591927	2	201727204	1078244	1068930		NC_000002.12:201727203:A:
NM_020919.4(ALS2):c.326del (p.Asn109fs)	ALS2	N109fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic	criteria provided, single submitter	VCV000988997	2	202626391	2	201761668	988997	976926		NC_000002.12:201761667:TT:T
NM_020919.4(ALS2):c.1815+4_1815+15del	ALS2		Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Jan 30, 2020)	criteria provided, single submitter	VCV000955265	2	202614420 - 202614431	2	201749697 - 201749708	955265	959622		NC_000002.12:201749696:AGTTCACAAAAG:
NM_020919.4(ALS2):c.4838+1del	ALS2		Infantile-onset ascending hereditary spastic paralysis	Likely pathogenic(Last reviewed: Jul 9, 2019)	criteria provided, single submitter	VCV000947373	2	202569176	2	201704453	947373	940685		NC_000002.12:201704452:CC:C
NM_020919.4(ALS2):c.2016_2026del (p.Val673fs)	ALS2	V673fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Apr 18, 2019)	criteria provided, single submitter	VCV000946562	2	202609125 - 202609135	2	201744402 - 201744412	946562	922519		NC_000002.12:201744401:CTGCTGTCACTCTGCT:CTGCT
NM_020919.4(ALS2):c.913del (p.Glu304_Leu305insTer)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000807369	2	202625804	2	201761081	807369	798496	rs1574786641	NC_000002.12:201761080:G:
NM_020919.4(ALS2):c.1054_1061del (p.Leu352fs)	ALS2	L352fs	Infantile-onset ascending hereditary spastic paralysis	Likely pathogenic(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000800527	2	202625656 - 202625663	2	201760933 - 201760940	800527	789113	rs1574786170	NC_000002.12:201760932:TCTGACAGT:T
NM_020919.4(ALS2):c.3860_3865del (p.Val1287_Pro1288del)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Uncertain significance(Last reviewed: Dec 5, 2018)	criteria provided, single submitter	VCV000580937	2	202580534 - 202580539	2	201715811 - 201715816	580937	559043	rs759145161	NC_000002.12:201715810:CTGGCACTG:CTG
NM_020919.4(ALS2):c.2491_2499del (p.Glu831_Leu833del)	ALS2		not specified|Infantile-onset ascending hereditary spastic paralysis	Conflicting interpretations of pathogenicity(Last reviewed: Jun 19, 2020)	criteria provided, conflicting interpretations	VCV000446821	2	202598080 - 202598088	2	201733357 - 201733365	446821	440650	rs773628251	NC_000002.12:201733356:CAGTATTTCCA:CA
NM_020919.4(ALS2):c.735_738del (p.Glu246fs)	ALS2	E246fs	Infantile-onset ascending hereditary spastic paralysis|not provided	Pathogenic(Last reviewed: Jun 26, 2018)	criteria provided, multiple submitters, no conflicts	VCV000419009	2	202625979 - 202625982	2	201761256 - 201761259	419009	405543	rs1064793583	NC_000002.12:201761255:TTCTTT:TT
NM_020919.4(ALS2):c.3625-16_3625-15del	ALS2		Amyotrophic Lateral Sclerosis, Recessive|not provided|ALS2-Related Disorders	Likely benign(Last reviewed: Jul 3, 2018)	criteria provided, multiple submitters, no conflicts	VCV000333591	2	202587858 - 202587859	2	201723135 - 201723136	333591	283970	rs370628135	NC_000002.12:201723134:AA:
NM_020919.4(ALS2):c.1425_1428del (p.Gly477fs)	ALS2	G477fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Jan 12, 2016)	criteria provided, single submitter	VCV000241308	2	202622168 - 202622171	2	201757445 - 201757448	241308	238594	rs878855058	NC_000002.12:201757444:CTCT:
NM_020919.4(ALS2):c.553del (p.Thr185fs)	ALS2	T185fs	Amyotrophic lateral sclerosis type 2, juvenile|Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Jan 16, 2020)	criteria provided, single submitter	VCV000004414	2	202626164	2	201761441	4414	19453	rs386134174	NC_000002.12:201761440:T:
NM_020919.4(ALS2):c.4721del (p.Val1574fs)	ALS2	V1574fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004412	2	202569294	2	201704571	4412	19451	rs386134188	NC_000002.12:201704570:A:
NM_020919.4(ALS2):c.1007_1008del (p.Ile336fs)	ALS2	I336fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Apr 2, 2018)	criteria provided, single submitter	VCV000004411	2	202625709 - 202625710	2	201760986 - 201760987	4411	19450	rs386134175	NC_000002.12:201760985:TAT:T
NM_020919.4(ALS2):c.2537_2538del (p.Asn846fs)	ALS2	N846fs	Infantile-onset ascending hereditary spastic paralysis	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004410	2	202598041 - 202598042	2	201733318 - 201733319	4410	19449	rs386134183	NC_000002.12:201733317:AT:
NM_020919.4(ALS2):c.3619del (p.Lys1206_Met1207insTer)	ALS2		Infantile-onset ascending hereditary spastic paralysis	Pathogenic	criteria provided, single submitter	VCV000004408	2	202588058	2	201723335	4408	19447	rs386134187	NC_000002.12:201723334:TTTT:TTT
NM_020919.4(ALS2):c.1867_1868del (p.Leu623fs)	ALS2	L623fs	Infantile-onset ascending hereditary spastic paralysis|Juvenile primary lateral sclerosis	Pathogenic(Last reviewed: Nov 12, 2018)	criteria provided, single submitter	VCV000004406	2	202611419 - 202611420	2	201746696 - 201746697	4406	19445	rs386134181	NC_000002.12:201746695:AG:
NM_020919.4(ALS2):c.138del (p.Ala47fs)	ALS2	A47fs	Amyotrophic lateral sclerosis type 2, juvenile	Pathogenic(Last reviewed: Feb 10, 2011)	no assertion criteria provided	VCV000004405	2	202631989	2	201767266	4405	19444	rs386134173	NC_000002.12:201767265:T:
NM_001031726.3(C19orf12):c.197_199del	C19orf12		not provided|Neurodegeneration with brain iron accumulation 4	Pathogenic(Last reviewed: Sep 1, 2020)	criteria provided, single submitter	VCV000088866	19	30193879 - 30193881	19	29702972 - 29702974	88866	94435	rs398122409	NC_000019.10:29702971:CCCCCCC:CCCC
NC_000022.11:g.(?_23765824)_(23767603_?)del	C22orf15|CHCHD10		Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Mar 20, 2019)	criteria provided, single submitter	VCV000831034	22	24108011 - 24109790			831034	821403		
NM_018325.5(C9orf72):c.1260-16_1260-14del	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366521	9	27548434 - 27548436	9	27548436 - 27548438	366521	318769	rs11292923	NC_000009.12:27548435:AAAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAA
NM_018325.5(C9orf72):c.1260-14del	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366520	9	27548434	9	27548436	366520	308091	rs11292923	NC_000009.12:27548435:AAAAAAAAAAAAAAAAAAAAAAAAAA:AAAAAAAAAAAAAAAAAAAAAAAAA
NM_018325.5(C9orf72):c.1260-15_1260-13del	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366515	9	27548433 - 27548435	9	27548435 - 27548437	366515	308084	rs886063843	NC_000009.12:27548434:GAA:
NM_018325.5(C9orf72):c.1260-14_1260-13del	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366514	9	27548433 - 27548434	9	27548435 - 27548436	366514	308082	rs886063842	NC_000009.12:27548434:GA:
NM_018325.5(C9orf72):c.*794_*797del	C9orf72		Amyotrophic Lateral Sclerosis/Frontotemporal Dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366493	9	27547437 - 27547440	9	27547439 - 27547442	366493	312430	rs886063834	NC_000009.12:27547438:ACAG:
NC_000010.10:g.(?_12833157)_(13178866_?)del	CAMK1D|CCDC3|OPTN		Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, e	Pathogenic(Last reviewed: Jun 14, 2017)	criteria provided, single submitter	VCV000584050	10	12833157 - 13178866			584050	564400		
NM_213720.3(CHCHD10):c.42-5del	CHCHD10		Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Likely benign(Last reviewed: Aug 1, 2019)	criteria provided, single submitter	VCV001160391	22	24109785	22	23767598	1160391	1149988		NC_000022.11:23767597:GGGGG:GGGG
NC_000022.10:g.(?_24109541)_(24110081_?)del	CHCHD10		Spinal muscular atrophy, jokela type|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Myopathy, isolated mitochondrial, autosomal dominant	Uncertain significance(Last reviewed: Mar 5, 2020)	criteria provided, single submitter	VCV001043025	22	24109541 - 24110081			1043025	1022425		
NM_213720.3(CHCHD10):c.410-8del	CHCHD10		Frontotemporal dementia and/or amyotrophic lateral sclerosis 2|Spinal muscular atrophy, jokela type|Myopathy, isolated mitochondrial, autosomal dominant	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000763752	22	24108221	22	23766034	763752	776953	rs759453467	NC_000022.11:23766033:GGG:GG
NC_000022.11:g.(?_23767364)_(23767982_?)del	CHCHD10		Spinal muscular atrophy, jokela type|Myopathy, isolated mitochondrial, autosomal dominant|Frontotemporal dementia and/or amyotrophic lateral sclerosis 2	Uncertain significance(Last reviewed: Nov 15, 2018)	criteria provided, single submitter	VCV000654106	22	24109551 - 24110169	22	23767364 - 23767982	654106	653271		
NM_000743.5(CHRNA3):c.725del (p.Leu242fs)	CHRNA3	L242fs	Amyotrophic lateral sclerosis	Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV000873308	15	78894259	15	78601917	873308	861402		NC_000015.10:78601916:AA:A
NM_004082.5(DCTN1):c.1288-7_1289del	DCTN1		Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: May 23, 2020)	criteria provided, single submitter	VCV001041586	2	74597195 - 74597203	2	74370068 - 74370076	1041586	1024728		NC_000002.12:74370067:ACCTGTGTTAC:AC
NC_000002.11:g.(?_74588271)_(74607174_?)del	DCTN1		Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Jan 23, 2020)	criteria provided, single submitter	VCV001015285	2	74588271 - 74607174			1015285	1001438		
NM_004082.5(DCTN1):c.2808del (p.Asp937fs)	DCTN1	D803fs, D920fs, D930fs, D900fs, D917fs, D937fs, D914fs	Amyotrophic lateral sclerosis type 1|Perry syndrome|Distal hereditary motor neuronopathy type 7B	Uncertain significance(Last reviewed: Aug 23, 2019)	criteria provided, single submitter	VCV000955782	2	74593098	2	74365971	955782	943130		NC_000002.12:74365970:T:
NM_004082.5(DCTN1):c.1392+8_1392+9del	DCTN1		not provided|Distal hereditary motor neuronopathy type 7B|Amyotrophic lateral sclerosis type 1|Perry syndrome	Likely benign(Last reviewed: Nov 7, 2018)	criteria provided, single submitter	VCV000794691	2	74597083 - 74597084	2	74369956 - 74369957	794691	787233	rs1573161311	NC_000002.12:74369955:TT:
NM_004082.5(DCTN1):c.142_143delinsAT (p.Gly48Ile)	DCTN1	G31I, G48I	Amyotrophic lateral sclerosis type 1|Distal hereditary motor neuronopathy type 7B|Perry syndrome	Uncertain significance(Last reviewed: Oct 3, 2018)	criteria provided, single submitter	VCV000658278	2	74605263 - 74605264	2	74378136 - 74378137	658278	630564	rs1573179028	NC_000002.12:74378135:CC:AT
NM_004082.5(DCTN1):c.-167del	DCTN1		Distal hereditary motor neuronopathy|Perry syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000337100	2	74607331	2	74380204	337100	290908	rs886056335	NC_000002.12:74380203:A:
NM_005235.3(ERBB4):c.884-7del	ERBB4		not provided|Amyotrophic lateral sclerosis 19	Benign(Last reviewed: Jul 30, 2021)	criteria provided, multiple submitters, no conflicts	VCV000769264	2	212578380	2	211713655	769264	777230	rs67894136	NC_000002.12:211713654:AAAAAAAAAAAAAA:AAAAAAAAAAAAA
NM_014845.6(FIG4):c.1150del (p.Arg384fs)	FIG4	R384fs	Amyotrophic lateral sclerosis type 11	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802256	6	110081462	6	109760259	802256	790574	rs1583695322	NC_000006.12:109760258:AAAA:AAA
NM_014845.6(FIG4):c.*150_*151del	FIG4		Amyotrophic Lateral Sclerosis, Dominant|Charcot-Marie-Tooth disease type 4	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000355053	6	110146618 - 110146619	6	109825415 - 109825416	355053	301223	rs886060986	NC_000006.12:109825414:AT:
NM_014845.6(FIG4):c.759del (p.Phe254fs)	FIG4		Charcot-Marie-Tooth disease|Charcot-Marie-Tooth disease type 4|Charcot-Marie-Tooth disease, type 4J|Amyotrophic lateral sclerosis type 11|not provided	Pathogenic(Last reviewed: Feb 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000254668	6	110059638	6	109738435	254668	249211	rs764717219	NC_000006.12:109738434:GGG:GG
NM_004960.4(FUS):c.684_692del (p.Gly229_Gly231del)	FUS		Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Tremor, hereditary essential, 4	Likely benign(Last reviewed: Apr 17, 2020)	criteria provided, single submitter	VCV001077589	16	31196418 - 31196426	16	31185097 - 31185105	1077589	1081989		NC_000016.10:31185096:GGCGGTGGTGG:GG
NM_004960.4(FUS):c.493_495del (p.Ser165del)	FUS	S165del, S164del	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Feb 18, 2019)	criteria provided, single submitter	VCV000850400	16	31195687 - 31195689	16	31184366 - 31184368	850400	843774		NC_000016.10:31184365:AGT:
NM_004960.4(FUS):c.291_292delinsTA (p.Pro98Thr)	FUS	P98T, P97T	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Nov 25, 2019)	criteria provided, single submitter	VCV000838008	16	31195279 - 31195280	16	31183958 - 31183959	838008	843773		NC_000016.10:31183957:CC:TA
NM_004960.4(FUS):c.1204_1206del (p.Ser402del)	FUS	S402del, S401del, S398del	Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Jul 26, 2019)	criteria provided, single submitter	VCV000653781	16	31201631 - 31201633	16	31190310 - 31190312	653781	644619	rs781120756	NC_000016.10:31190309:AGT:
NM_004960.4(FUS):c.661_663del (p.Ser221del)	FUS	S221del, S217del, S220del	not provided|Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Tremor, hereditary essential, 4	Uncertain significance(Last reviewed: Mar 22, 2018)	criteria provided, multiple submitters, no conflicts	VCV000503718	16	31196397 - 31196399	16	31185076 - 31185078	503718	495622	rs746633090	NC_000016.10:31185075:AGT:
NM_004960.4(FUS):c.681_689del (p.Gly229_Gly231del)	FUS		Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Tremor, hereditary essential, 4|not provided|not specified	Conflicting interpretations of pathogenicity(Last reviewed: Mar 1, 2021)	criteria provided, conflicting interpretations	VCV000447358	16	31196415 - 31196423	16	31185094 - 31185102	447358	441902	rs767564995	NC_000016.10:31185093:GGCGGCGGTGG:GG
NM_004960.4(FUS):c.1394-2del	FUS		not provided|Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia|Tremor, hereditary essential, 4	Pathogenic(Last reviewed: Jan 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000447355	16	31202282	16	31190961	447355	441905	rs1555509569	NC_000016.10:31190960:A:
NM_004960.4(FUS):c.13+11_13+13del	FUS		Dystonia|Myoclonus|Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Oct 19, 2018)	criteria provided, single submitter	VCV000374092	16	31191558 - 31191560	16	31180237 - 31180239	374092	360997	rs1057518893	NC_000016.10:31180236:GGCG:G
NM_001170634.1(FUS):c.*2393del	FUS		Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319039	16	31205141	16	31193820	319039	341312	rs753379140	NC_000016.10:31193819:TTTTTTTTTTTT:TTTTTTTTTTT
NM_001170634.1(FUS):c.*1145_*1146del	FUS		Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000319010	16	31203903 - 31203904	16	31192582 - 31192583	319010	342779	rs1211904015	NC_000016.10:31192581:ACA:A
NM_002137.4(HNRNPA2B1):c.7-143del	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Benign(Last reviewed: Jun 1, 2020)	criteria provided, single submitter	VCV001170361	7	26237495	7	26197875	1170361	1155684		NC_000007.14:26197874:AAAAAAAAAA:AAAAAAAAA
NM_002137.4(HNRNPA2B1):c.984_992del (p.329_331SGG[1])	HNRNPA2B1		Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	Uncertain significance(Last reviewed: Sep 17, 2017)	criteria provided, single submitter	VCV000541427	7	26232170 - 26232178	7	26192550 - 26192558	541427	522884	rs754021381	NC_000007.14:26192549:CCTCCACTGCCTCC:CCTCC
NM_001008212.2(OPTN):c.76del (p.His26fs)	LOC108903148|OPTN	H26fs	Amyotrophic lateral sclerosis type 12	Pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV000873264	10	13151192	10	13109192	873264	861365		NC_000010.11:13109191:CCCCCCC:CCCCCC
NC_000010.11:g.(?_13109123)_(13183100_?)del	LOC108903148|LOC108903149|LOC121366042|MCM10|OPTN		Primary open angle glaucoma|Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, e	Pathogenic(Last reviewed: Jan 26, 2018)	criteria provided, single submitter	VCV000583651	10	13151123 - 13225100	10	13109123 - 13183100	583651	564407		
NM_018834.6(MATR3):c.1434+10del	MATR3		Amyotrophic lateral sclerosis 21	Likely benign(Last reviewed: Sep 13, 2020)	criteria provided, single submitter	VCV001155218	5	138654732	5	139319043	1155218	1136552		NC_000005.10:139319042:A:
NM_018834.6(MATR3):c.1885_1887del (p.Glu629del)	MATR3	E341del, E629del, E291del	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Feb 14, 2020)	criteria provided, single submitter	VCV000862631	5	138658393 - 138658395	5	139322704 - 139322706	862631	830357		NC_000005.10:139322703:GAG:
NM_018834.6(MATR3):c.493_495del (p.Ala165del)	MATR3	A165del	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Nov 18, 2019)	criteria provided, single submitter	VCV000838160	5	138643595 - 138643597	5	139307906 - 139307908	838160	830353		NC_000005.10:139307905:CTGCT:CT
NM_018834.6(MATR3):c.628_630del (p.Glu210del)	MATR3	E210del	Amyotrophic lateral sclerosis 21	Uncertain significance(Last reviewed: Dec 18, 2019)	criteria provided, single submitter	VCV000837241	5	138643730 - 138643732	5	139308041 - 139308043	837241	830354		NC_000005.10:139308040:AAGAA:AA
NM_018834.6(MATR3):c.1603-9_1603-8del	MATR3		not provided|Amyotrophic lateral sclerosis 21	Likely benign(Last reviewed: Dec 6, 2018)	criteria provided, single submitter	VCV000796566	5	138657577 - 138657578	5	139321888 - 139321889	796566	787470	rs1581255414	NC_000005.10:139321887:TCT:T
NM_021076.4(NEFH):c.1376_1379del (p.Glu459fs)	NEFH	E459fs	Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Nov 27, 2019)	criteria provided, single submitter	VCV000976269	22	29885005 - 29885008	22	29489016 - 29489019	976269	964552		NC_000022.11:29489015:AACA:
NM_021076.4(NEFH):c.2368_2370del (p.Lys790del)	NEFH	K790del	not provided|Amyotrophic lateral sclerosis type 1	Conflicting interpretations of pathogenicity(Last reviewed: Jul 20, 2021)	criteria provided, conflicting interpretations	VCV000066740	22	29885997 - 29885999	22	29490008 - 29490010	66740	77637	rs59551486	NC_000022.11:29490007:AAG:
NM_021076.4(NEFH):c.2232_2249del (p.746_751SPEKAK[1])	NEFH		not provided|Amyotrophic lateral sclerosis type 1	Benign(Last reviewed: May 4, 2021)	criteria provided, multiple submitters, no conflicts	VCV000066738	22	29885859 - 29885876	22	29489870 - 29489887	66738	77635	rs59890097	NC_000022.11:29489869:GCTAAGTCCCCAGAGAAGGC:GC
NM_001008212.2(OPTN):c.626+5del	OPTN		Amyotrophic lateral sclerosis type 12|Glaucoma 1, open angle, e|Primary open angle glaucoma	Uncertain significance(Last reviewed: Aug 22, 2020)	criteria provided, single submitter	VCV001038831	10	13158345	10	13116345	1038831	1029474		NC_000010.11:13116344:G:
NM_001008212.2(OPTN):c.1217del (p.Thr406fs)	OPTN	T406fs	Amyotrophic lateral sclerosis type 12	Pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV000873267	10	13168014	10	13126014	873267	861368		NC_000010.11:13126013:C:
NM_001008212.2(OPTN):c.1078_1079del (p.Lys360fs)	OPTN	K360fs	not provided|Amyotrophic lateral sclerosis type 12	Pathogenic/Likely pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000873266	10	13167494 - 13167495	10	13125494 - 13125495	873266	861367		NC_000010.11:13125493:AAAAA:AAA
NC_000010.11:g.(?_13109113)_(13112645_?)del	OPTN		Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, e	Pathogenic(Last reviewed: Sep 3, 2019)	criteria provided, single submitter	VCV000832940	10	13151113 - 13154645			832940	820193		
NC_000010.11:g.(?_13118878)_(13119050_?)del	OPTN		Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, e	Uncertain significance(Last reviewed: Nov 22, 2019)	criteria provided, single submitter	VCV000832895	10	13160878 - 13161050			832895	820195		
NC_000010.11:g.(?_13116257)_(13116350_?)del	OPTN		Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma|Glaucoma 1, open angle, e	Pathogenic(Last reviewed: May 29, 2019)	criteria provided, single submitter	VCV000831344	10	13158257 - 13158350			831344	820194		
NC_000010.11:g.(?_13109103)_(13136886_?)del	OPTN|LOC108903148|LOC108903149		Glaucoma 1, open angle, e|Amyotrophic lateral sclerosis type 12|Primary open angle glaucoma	Pathogenic(Last reviewed: Dec 7, 2017)	criteria provided, single submitter	VCV000529764	10	13151103 - 13178886	10	13109103 - 13136886	529764	525242		
OPTN, EX5DEL	OPTN		Amyotrophic lateral sclerosis type 12	Pathogenic(Last reviewed: May 13, 2010)	no assertion criteria provided	VCV000007100					7100	22139		
NM_005022.4(PFN1):c.350_351delinsGT (p.Glu117Gly)	PFN1	E117G	not provided	Conflicting interpretations of pathogenicity(Last reviewed: Sep 3, 2020)	criteria provided, conflicting interpretations	VCV000646360	17	4849267 - 4849268	17	4945972 - 4945973	646360	646165	rs1597686012	NC_000017.11:4945971:TT:AC
NM_000305.3(PON2):c.286del (p.Arg96fs)	PON2	R96fs	not specified	Uncertain significance(Last reviewed: Dec 29, 2020)	criteria provided, single submitter	VCV000992254	7	95041705	7	95412393	992254	980165		NC_000007.14:95412392:TT:T
PRPH, 1-BP DEL, 228C	PRPH		Amyotrophic lateral sclerosis, susceptibility to	risk factor(Last reviewed: Oct 29, 2004)	no assertion criteria provided	VCV000013706					13706	28745		
NM_015046.7(SETX):c.1989_1994del (p.Ile664_Glu665del)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Uncertain significance(Last reviewed: Feb 29, 2020)	criteria provided, single submitter	VCV001063249	9	135204991 - 135204996	9	132329604 - 132329609	1063249	1045948		NC_000009.12:132329603:TCTATA:
NM_015046.7(SETX):c.2387_2390del (p.Lys796fs)	SETX	K796fs	Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Oct 15, 2019)	criteria provided, single submitter	VCV000959106	9	135204595 - 135204598	9	132329208 - 132329211	959106	946415		NC_000009.12:132329207:TTCTTT:TT
NM_015046.7(SETX):c.6843-3_6843-1del	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, single submitter	VCV000838820	9	135152540 - 135152542	9	132277153 - 132277155	838820	852492		NC_000009.12:132277152:CTG:
NC_000009.12:g.(?_132334598)_(132334737_?)del	SETX		Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Uncertain significance(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000830654	9	135209985 - 135210124			830654	820081		
NM_015046.7(SETX):c.6996_7002del (p.Asp2332fs)	SETX	D2332fs	Amyotrophic lateral sclerosis type 4	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000802521	9	135150741 - 135150747	9	132275354 - 132275360	802521	790848	rs1362178149	NC_000009.12:132275353:TCTTTTGTCTTT:TCTTT
NM_015046.7(SETX):c.5264del (p.Thr1755fs)	SETX	T1755fs	Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Pathogenic(Last reviewed: Aug 14, 2018)	criteria provided, single submitter	VCV000572675	9	135201721	9	132326334	572675	568595	rs776632212	NC_000009.12:132326333:G:
NM_015046.7(SETX):c.3162_3167del (p.Asn1054_Ser1055del)	SETX		Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|Amyotrophic lateral sclerosis type 4	Likely benign(Last reviewed: Dec 31, 2019)	criteria provided, single submitter	VCV000468498	9	135203818 - 135203823	9	132328431 - 132328436	468498	458990	rs576141809	NC_000009.12:132328430:TTACTATTA:TTA
NM_015046.7(SETX):c.1427_1432del (p.His476_Leu477del)	SETX		not specified|not provided|none provided|Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2	Uncertain significance(Last reviewed: Apr 24, 2020)	criteria provided, multiple submitters, no conflicts	VCV000448305	9	135205553 - 135205558	9	132330166 - 132330171	448305	441308	rs777314512	NC_000009.12:132330165:GCAAATGCAAA:GCAAA
NM_015046.7(SETX):c.7200-11_7200-10del	SETX		not provided|Amyotrophic lateral sclerosis type 4|Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2|not specified	Benign(Last reviewed: Nov 13, 2020)	criteria provided, multiple submitters, no conflicts	VCV000440265	9	135145099 - 135145100	9	132269712 - 132269713	440265	433911	rs531485265	NC_000009.12:132269711:AAAAAAA:AAAAA
NM_015046.7(SETX):c.389-9del	SETX		Amyotrophic Lateral Sclerosis, Dominant|Ataxia with Oculomotor Apraxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365377	9	135218195	9	132342808	365377	311342	rs534931548	NC_000009.12:132342807:AAAAAAA:AAAAAA
NM_015046.7(SETX):c.*431_*432del	SETX		Ataxia with Oculomotor Apraxia|not provided|Amyotrophic Lateral Sclerosis, Dominant	Benign/Likely benign(Last reviewed: May 16, 2021)	criteria provided, multiple submitters, no conflicts	VCV000365332	9	135139194 - 135139195	9	132263807 - 132263808	365332	307148	rs112251805	NC_000009.12:132263806:TCT:T
NM_015046.7(SETX):c.*2576_*2577del	SETX		Amyotrophic Lateral Sclerosis, Dominant|Ataxia with Oculomotor Apraxia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000365303	9	135137049 - 135137050	9	132261662 - 132261663	365303	317274	rs886063544	NC_000009.12:132261661:TTTTT:TTT
NC_000009.11:g.34637990_34637991delinsAA	SIGMAR1		Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV001165217	9	34637990 - 34637991	9	34637993 - 34637994	1165217	1156210		NC_000009.12:34637992:GC:AA
NM_005866.4(SIGMAR1):c.19del (p.Arg7fs)	SIGMAR1	R7fs	Distal spinal muscular atrophy, autosomal recessive 2|Amyotrophic lateral sclerosis 16, juvenile	Pathogenic(Last reviewed: Feb 15, 2020)	criteria provided, single submitter	VCV000650504	9	34637676	9	34637679	650504	638215	rs747285235	NC_000009.12:34637678:GG:G
NM_005866.4(SIGMAR1):c.13del (p.Val5fs)	SIGMAR1	V5fs	Amyotrophic lateral sclerosis 16, juvenile|Distal spinal muscular atrophy, autosomal recessive 2	Pathogenic(Last reviewed: Dec 14, 2018)	criteria provided, single submitter	VCV000569448	9	34637682	9	34637685	569448	565883	rs1564096761	NC_000009.12:34637684:C:
NM_005866.4(SIGMAR1):c.561_576del (p.Asp188fs)	SIGMAR1	D168fs, D157fs, D188fs, D88fs	Amyotrophic lateral sclerosis 16, juvenile	Likely pathogenic	criteria provided, single submitter	VCV000431075	9	34635725 - 34635740	9	34635728 - 34635743	431075	424598	rs1554707680	NC_000009.12:34635727:GCTGAAGACAGTGTCGGC:GC
NM_005866.4(SIGMAR1):c.446-25_*40del	SIGMAR1		Amyotrophic lateral sclerosis 16, juvenile	Likely pathogenic	criteria provided, single submitter	VCV000431074	9	34635589 - 34635880	9	34635592 - 34635883	431074	424599	rs1554707622	
NM_033409.4(SLC52A3):c.85del (p.Leu29fs)	SLC52A3	L29fs	Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Jul 20, 2020)	criteria provided, single submitter	VCV001074049	20	746334	20	765690	1074049	1064880		NC_000020.11:765689:GGGG:GGG
NC_000020.10:g.(?_745957_749607del	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Sep 19, 2019)	criteria provided, single submitter	VCV001068731					1068731	1058090		
NM_033409.4(SLC52A3):c.1327_1338del (p.Gly443_Leu446del)	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Uncertain significance(Last reviewed: Dec 18, 2018)	criteria provided, single submitter	VCV000645920	20	741742 - 741753	20	761098 - 761109	645920	648851	rs1462694166	NC_000020.11:761097:GAGCAGCGCTCCGAGCAGCG:GAGCAGCG
NC_000020.11:g.(?_761006)_(765794_?)del	SLC52A3		Brown-Vialetto-Van Laere syndrome 1	Pathogenic(Last reviewed: Jul 20, 2018)	criteria provided, single submitter	VCV000640455	20	741650 - 746438	20	761006 - 765794	640455	653115		
NM_033409.4(SLC52A3):c.753del (p.Val252fs)	SLC52A3	V252fs	Brown-Vialetto-Van Laere syndrome 1	Pathogenic/Likely pathogenic(Last reviewed: Nov 7, 2019)	criteria provided, multiple submitters, no conflicts	VCV000623230	20	744462	20	763818	623230	612166	rs1568721373	NC_000020.11:763817:GG:G
NM_033409.4(SLC52A3):c.-14_-6del	SLC52A3		not specified|not provided|Brown-Vialetto-Van Laere syndrome 1|Progressive bulbar palsy of childhood	Benign(Last reviewed: Jul 14, 2021)	criteria provided, multiple submitters, no conflicts	VCV000262228	20	746424 - 746432	20	765780 - 765788	262228	257443	rs11467076	NC_000020.11:765779:TATCTGCCCT:T
NM_033409.4(SLC52A3):c.1325_1326del (p.Leu442fs)	SLC52A3	L442fs	Brown-Vialetto-Van Laere syndrome 1|not provided	Likely pathogenic(Last reviewed: May 30, 2017)	criteria provided, single submitter	VCV000000139	20	741754 - 741755	20	761110 - 761111	139	15178	rs794728004	NC_000020.11:761109:GAG:G
NM_000454.5(SOD1):c.169+52_169+58del	SOD1		Amyotrophic lateral sclerosis type 1|not provided	Benign(Last reviewed: Sep 16, 2020)	criteria provided, multiple submitters, no conflicts	VCV001170537	21	33036249 - 33036255	21	31663936 - 31663942	1170537	1158954		NC_000021.9:31663935:TAAACAGTA:TA
NM_000454.5(SOD1):c.149del (p.Glu50fs)	SOD1	E50fs	Amyotrophic lateral sclerosis type 1	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000946758	21	33036179	21	31663866	946758	929280		NC_000021.9:31663865:A:
SOD1, 6-BP DEL, GGACCA	SOD1		Amyotrophic lateral sclerosis type 1	Pathogenic(Last reviewed: Mar 31, 2009)	no assertion criteria provided	VCV000014785					14785	29824		
NM_025137.4(SPG11):c.2250del (p.Phe750fs)	SPG11	F750fs	Amyotrophic lateral sclerosis type 5	Pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV000873263	15	44914992	15	44622794	873263	861398		NC_000015.10:44622793:AAA:AA
NM_025137.4(SPG11):c.1966_1967del (p.Lys656fs)	SPG11	K656fs	Amyotrophic lateral sclerosis type 5	Likely pathogenic(Last reviewed: Mar 31, 2020)	criteria provided, single submitter	VCV000873262	15	44920967 - 44920968	15	44628769 - 44628770	873262	861399		NC_000015.10:44628768:TTT:T
NM_025137.4(SPG11):c.5199del (p.Lys1733fs)	SPG11	K1733fs	Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5|Charcot-Marie-Tooth disease, axonal type 2X	Likely pathogenic(Last reviewed: Jun 20, 2019)	criteria provided, single submitter	VCV000804472	15	44876679	15	44584481	804472	792796	rs779268551	NC_000015.10:44584480:TTTTTT:TTTTT
NM_025137.4(SPG11):c.733_734del (p.Met245fs)	SPG11	M245fs	Spastic paraplegia 11, autosomal recessive|not provided|Spastic paraplegia 11, autosomal recessive|Amyotrophic lateral sclerosis type 5|Inborn genetic diseases|Amyotrophic lateral sclerosis type 5|Hereditary spastic paraplegia	Pathogenic(Last reviewed: Nov 2, 2021)	criteria provided, multiple submitters, no conflicts	VCV000001112	15	44949428 - 44949429	15	44657230 - 44657231	1112	16151	rs312262720	NC_000015.10:44657229:AT:
NM_006415.4(SPTLC1):c.118_123del (p.Phe40_Ser41del)	SPTLC1		Amyotrophic lateral sclerosis	Likely pathogenic	criteria provided, single submitter	VCV000997832	9	94874779 - 94874784	9	92112497 - 92112502	997832	985550		NC_000009.12:92112496:AGAGAAA:A
NM_003900.5(SQSTM1):c.1166-14_1166-11del	SQSTM1		Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Benign(Last reviewed: Dec 3, 2020)	criteria provided, single submitter	VCV001166392	5	179263420 - 179263423	5	179836420 - 179836423	1166392	1155044		NC_000005.10:179836419:CTTACT:CT
NM_003900.5(SQSTM1):c.1170del (p.Asp391fs)	SQSTM1	D307fs, D391fs	Paget disease of bone 2, early-onset|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Pathogenic(Last reviewed: Aug 6, 2020)	criteria provided, single submitter	VCV001069495	5	179263440	5	179836440	1069495	1060385		NC_000005.10:179836439:T:
NM_003900.5(SQSTM1):c.309_311del (p.Glu104del)	SQSTM1	E104del, E20del	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Uncertain significance(Last reviewed: Jun 27, 2020)	criteria provided, single submitter	VCV001054742	5	179250864 - 179250866	5	179823864 - 179823866	1054742	1043538		NC_000005.10:179823863:AAGA:A
NM_003900.5(SQSTM1):c.1060del (p.Gln354fs)	SQSTM1	Q270fs, Q354fs	Paget disease of bone 2, early-onset|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Uncertain significance(Last reviewed: Jan 8, 2020)	criteria provided, single submitter	VCV001009953	5	179260676	5	179833676	1009953	990899		NC_000005.10:179833675:CC:C
NM_003900.5(SQSTM1):c.1128del (p.Gly376_Leu377insTer)	SQSTM1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 3	Likely pathogenic(Last reviewed: Dec 10, 2018)	criteria provided, single submitter	VCV000976342	5	179260743	5	179833743	976342	964254		NC_000005.10:179833742:GGG:GG
NM_003900.5(SQSTM1):c.810del (p.Val271fs)	SQSTM1	V187fs, V271fs	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Pathogenic(Last reviewed: Jan 15, 2020)	criteria provided, single submitter	VCV000967349	5	179260083	5	179833083	967349	954149		NC_000005.10:179833082:CCCCC:CCCC
NC_000005.10:g.(?_179836426)_(179836603_?)del	SQSTM1		Paget disease of bone 2, early-onset|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Uncertain significance(Last reviewed: Dec 30, 2019)	criteria provided, single submitter	VCV000832937	5	179263426 - 179263603			832937	819585		
NM_003900.5(SQSTM1):c.206-7_206-4del	SQSTM1		not provided|Paget disease of bone 2, early-onset|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Likely benign(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV000773989	5	179249950 - 179249953	5	179822950 - 179822953	773989	777498	rs779766449	NC_000005.10:179822949:CAATC:C
NM_003900.5(SQSTM1):c.301+13_301+24del	SQSTM1		not provided|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset	Likely benign(Last reviewed: Feb 21, 2018)	criteria provided, single submitter	VCV000748683	5	179250058 - 179250069	5	179823058 - 179823069	748683	759588	rs1582006453	NC_000005.10:179823057:GGGGCTGCTCTGGGGGCTGC:GGGGCTGC
NM_003900.4(SQSTM1):c.970delG (p.Glu324Asnfs)	SQSTM1		not provided|Paget disease of bone 2, early-onset|Amyotrophic lateral sclerosis and/or frontotemporal dementia 1	Uncertain significance(Last reviewed: Aug 28, 2020)	criteria provided, multiple submitters, no conflicts	VCV000542159	5	179260586	5	179833586	542159	521649	rs758377403	NC_000005.10:179833585:GG:G
NM_003900.5(SQSTM1):c.526_529del (p.Ser176fs)	SQSTM1	S176fs, S92fs	Amyotrophic lateral sclerosis and/or frontotemporal dementia 1|Paget disease of bone 2, early-onset|not provided	Pathogenic(Last reviewed: Dec 27, 2019)	criteria provided, multiple submitters, no conflicts	VCV000503881	5	179251079 - 179251082	5	179824079 - 179824082	503881	495500	rs1331685476	NC_000005.10:179824078:CTGTCTG:CTG
NM_198935.3(SS18L1):c.660_668del (p.219QGS[1])	SS18L1		not provided	Uncertain significance(Last reviewed: May 1, 2014)	no assertion criteria provided	VCV000144010	20	60738612 - 60738620	20	62163556 - 62163564	144010	153741	rs587777634	NC_000020.11:62163555:CAGGGCAGCCAGGG:CAGGG
NM_007375.4(TARDBP):c.*2538del	TARDBP		Frontotemporal dementia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291767	1	11085248	1	11025191	291767	275875	rs886045050	NC_000001.11:11025190:CC:C
NM_007375.4(TARDBP):c.*1633del	TARDBP		Frontotemporal dementia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291755	1	11084334	1	11024277	291755	275867	rs886045043	NC_000001.11:11024276:TTTTTTTTTTT:TTTTTTTTTT
NM_007375.4(TARDBP):c.*1597_*1600del	TARDBP		Frontotemporal dementia|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291753	1	11084306 - 11084309	1	11024249 - 11024252	291753	275859	rs748047297	NC_000001.11:11024248:TTTGTT:TT
NM_007375.4(TARDBP):c.*505del	TARDBP		Amyotrophic Lateral Sclerosis, Dominant|Frontotemporal dementia	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291745	1	11083213	1	11023156	291745	275994	rs886045038	NC_000001.11:11023155:AAAA:AAA
NM_007375.4(TARDBP):c.-12-10_-12-9del	TARDBP		Frontotemporal dementia|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000291733	1	11073761 - 11073762	1	11013704 - 11013705	291733	275813	rs575825467	NC_000001.11:11013703:TTTT:TT
NM_013254.4(TBK1):c.1740del (p.Glu580fs)	TBK1	E580fs	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Sep 9, 2020)	criteria provided, single submitter	VCV001073720	12	64890165	12	64496385	1073720	1062699		NC_000012.12:64496384:AA:A
NM_013254.4(TBK1):c.2080_2082del (p.Lys694del)	TBK1	K694del	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Uncertain significance(Last reviewed: Jul 24, 2019)	criteria provided, single submitter	VCV000935520	12	64891761 - 64891763	12	64497981 - 64497983	935520	936232		NC_000012.12:64497980:AAG:
GRCh37/hg19 12q14.2(chr12:64868010-64895161)	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Jan 23, 2018)	criteria provided, single submitter	VCV000813327	12	64868010 - 64895161			813327	801575		
NM_013254.4(TBK1):c.540+8_540+9del	TBK1		not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Likely benign(Last reviewed: Oct 2, 2018)	criteria provided, single submitter	VCV000763118	12	64860870 - 64860871	12	64467090 - 64467091	763118	775981	rs761043079	NC_000012.12:64467089:AT:
NM_013254.4(TBK1):c.1954_1956del (p.Asn652del)	TBK1	N652del	not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Benign(Last reviewed: Jun 8, 2020)	criteria provided, multiple submitters, no conflicts	VCV000702184	12	64891033 - 64891035	12	64497253 - 64497255	702184	693279	rs141727722	NC_000012.12:64497252:TAAT:T
NM_013254.4(TBK1):c.1387_1388del (p.Glu463fs)	TBK1	E463fs	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: Nov 10, 2017)	criteria provided, single submitter	VCV000542552	12	64882312 - 64882313	12	64488532 - 64488533	542552	527327	rs1555204731	NC_000012.12:64488531:AGA:A
NM_013254.4(TBK1):c.1341-3del	TBK1		Frontotemporal dementia and/or amyotrophic lateral sclerosis 4|not provided	Benign(Last reviewed: Nov 15, 2020)	criteria provided, multiple submitters, no conflicts	VCV000475934	12	64882258	12	64488478	475934	463300	rs201728462	NC_000012.12:64488477:TTTTTTT:TTTTTT
NM_013254.3(TBK1):c.1644-5_1644-2del	TBK1		not provided|Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Conflicting interpretations of pathogenicity(Last reviewed: Jul 26, 2019)	criteria provided, conflicting interpretations	VCV000444300	12	64889472 - 64889475	12	64495692 - 64495695	444300	437940	rs755646937	NC_000012.12:64495691:TAAATA:TA
NM_013254.4(TBK1):c.958del (p.Thr320fs)	TBK1	T320fs	Frontotemporal dementia and/or amyotrophic lateral sclerosis 4	Pathogenic(Last reviewed: May 1, 2015)	no assertion criteria provided	VCV000203438	12	64875767	12	64481987	203438	199851	rs755950225	NC_000012.12:64481986:A:
NC_000020.11:g.(?_58389109)_(58389527_?)del	VAPB		Spinal muscular atrophy, late-onset, finkel type|Amyotrophic lateral sclerosis type 8	Uncertain significance(Last reviewed: Feb 26, 2019)	criteria provided, single submitter	VCV000831928	20	56964165 - 56964583			831928	821335		
NM_004738.5(VAPB):c.*6257del	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339021	20	57025548	20	58450492	339021	345745	rs750250276	NC_000020.11:58450491:T:
NM_004738.5(VAPB):c.*5511_*5513del	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339008	20	57024801 - 57024803	20	58449745 - 58449747	339008	351279	rs556955970	NC_000020.11:58449744:GCTG:G
NM_004738.5(VAPB):c.*5233_*5237del	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000339004	20	57024523 - 57024527	20	58449467 - 58449471	339004	350220	rs546553846	NC_000020.11:58449466:TTTATT:T
NM_004738.5(VAPB):c.*4306del	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Likely benign(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338991	20	57023593	20	58448537	338991	351273	rs536996969	NC_000020.11:58448536:TTTTT:TTTT
NM_004738.5(VAPB):c.*200_*214delinsGTTGAGGGGGAAACATTAAAAG	VAPB		Spinal Muscular Atrophy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000338935	20	57019491 - 57019505	20	58444435 - 58444449	338935	350191	rs386815633	NC_000020.11:58444434:ATGTATAGTAACTGA:GTTGAGGGGGAAACATTAAAAG
NM_007126.5(VCP):c.446-4_446-3delinsAT	VCP		Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia|Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	Uncertain significance(Last reviewed: Apr 17, 2019)	criteria provided, single submitter	VCV000842949	9	35065381 - 35065382	9	35065384 - 35065385	842949	851337		NC_000009.12:35065383:GC:AT
NM_007126.5(VCP):c.*384del	VCP		Inclusion Body Myopathy, Dominant|Amyotrophic Lateral Sclerosis, Dominant	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000366709	9	35056730	9	35056733	366709	312615	rs532445930	NC_000009.12:35056732:A:
